Recent Posts in FDA Warnings Category
Posted on Oct 27, 2011 By Jennifer Williams
The FDA released the report today from its study of the relative risks of various combined hormonal contraceptives (CHCs). The study compared recently marketed CHCs including Yasmin/Yaz, Ortho Evra ...
Continue reading "Report from FDA-funded study confirms increased risk of VTEs in users of Yasmin and Yaz" »
Posted on Sep 27, 2011 By Jennifer Williams
On September 26, 2011 the FDA issued a Drug Safety Communication regarding its safety review of drospirenone-containing oral contraceptives such as Yasmin and Yaz. The FDA bulletin states that while ...
Continue reading "FDA to Convene Panel to Weigh Risks of Yasmin and Yaz" »
Posted on Jun 1, 2011 By Jackson Allen Williams, LLP
On May 31, 2011 the FDA issued a safety alert warning of a possible increased risk of blood clots associated with birth control pills containing drospirenone. Drospirenone is a hormone found in the ...
Continue reading "FDA Warns of Increased Risk of Blood Clots with Yaz and Yasmin" »
Posted on Apr 16, 2010 By Jennifer Williams
On April 9, 2010, a press release from Bayer stated it will update the labels for Yaz and Yasmin. The statement from Bayer indicates that the FDA has approved the new labels for Yaz and Yasmin. The ...
Continue reading "Bayer Updates Labels for Yaz and Yasmin" »
Posted on Nov 19, 2009 By Jennifer Williams
Bayer is using Yaz as a pilot for the new Google sponsored links format proposed at FDA hearings last week. The new format was created in response to FDA warnings regarding the lack of safety ...
Continue reading "Bayer Continues Agressive Advertising of Yaz" »